Navigation Links
EQLB Releases Letter to Shareholders

LAS VEGAS, Sept. 14 /PRNewswire-FirstCall/ -- EQ Labs, Inc. (Pink Sheets: EQLB) announced today that on Saturday, August 29, 2009, the Company held its first public stockholders' meeting at its headquarters in Las Vegas, Nevada with Maurice "Mo" Owens, the Company's Chairman of the Board and CEO presiding. The Board of Directors of EQ Labs is pleased to announce that all of the recommendations of the Board and the resolutions placed before the shareholders were approved during the shareholder meeting.

Investors traveled from throughout the United States to attend the Company's first annual shareholder meeting and an equally significant number of investors were able to participate in the event online.

One of the most noteworthy highlights of the meeting was Owens' overview of the Company's research and development activities which have developed three new flavors of the EQ Smart Energy Drink tablets: Strawberry Dream, Mo Apple, and Lemon Lime. These new flavors, when combined with water or another beverage of choice, taste more like fruit drinks and are in no way similar in taste to other energy drinks already on the market.

"With a Manufacturers Suggested Retail Price (MSRP) of less than one dollar per tablet, we expect these exciting new flavors to fare very well with consumers," Owens commented. "The fact of the matter is, these new flavors came out over a month ago and were immediately marketed to our current distributors and wholesalers (collectively representing over 100,000 points of sale), who have responded very positively."

"The next phase of this marketing initiative will entail expanding the demand for these effervescent tablets with new consumer oriented retail organizations so that they too might 'think outside the can' and appreciate the impact, unique characteristics of this product, and income potential," Owens concluded.

About EQ Labs, Inc.

EQ Smart Energy Drink(R) is an effervescent tablet that provides instant energy in any beverage. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee, EQ keeps you going any time - - day or night. Since one tablet of EQ Smart Energy Drink(R) is the equivalent of one can of any competing energy drink on the market, it is more economically efficient and convenient for consumer usage than most energy drink products in the marketplace. EQ is sold either in packets of one single tablet or three-inch tubes of six tablets. The product does not have to be kept cold to enjoy nor does it require a lot of space. As an example, a three-inch tube containing six tablets can be transported in a pocket or purse, and yet it is the equivalent of 6 cans of energy drink, when combined with eight - ten ounces of any beverage, at a significant cost savings. EQ is all about energy and living the All-American Lifestyle.

The Company presently distributes its products through national distributors, such as McLane Distributors, which distributes to the national convenience store chain, 7-Eleven, and numerous other regional distributors, and has been approved for consumer consumption by the Ministries of Health in Latin America countries such as Mexico and Brazil. Similar approval is pending in Brazil, where the largest nation-wide pharmacy chains have formally requested national distribution privileges.

The Company sponsors athletes from a diverse field to assist in promoting its products. EQ Labs, Inc. sponsored the off-track racing teams that won 1st Place (in Series 5) in the prestigious Baja 1000 in 2007, the LVDC team who won the 2008 Baja 1000 and has won 1st Place trophies in 15 of its last 17 races, with the EQ brand prominently displayed by the drivers and their crew.

Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EQ Labs, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


    Maurice "Mo" Owens, CEO
    EQ Labs, Inc.
    TEL: 702-445-7762 Email:; or
    Bob Fain, COO
    Email:, and
    Web Sites:

SOURCE EQ Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HRSA Releases $24.5 Million in Grants to Support Poison Control Centers
2. Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs
3. OAG Releases Prototype for Pandemic Disease Planning and Management
4. Neusoft Announces New Releases of Flagship Medical Products
5. Center for Technology and Aging Releases Guidelines for $500,000 Medication Optimization Diffusion Grants Program
6. Saddle Ranch Productions Announces New Releases
7. Pump Up The Volume: Equinox Releases Exclusive Celebrity Playlists
8. First Defense Nasal Screen Comp. Releases New Protection Product Just in Time for Pandemic Flu Season
9. VHI Releases Consumer Guide to Obstetrical Services in Virginia
10. To Help People Weather the Health Care Crisis, Releases its Newest Feature: Barter for Health Care
11. Blue Cross Blue Shield of Michigan Releases Letter Sent to Congressmen John Dingell and Sander Levin
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive ... two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, New ... PROTECTOR to save the expense of having to replace NuvaRings more often than necessary. ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... through sharing, the 2016 Building Better Radiology Marketing Programs meeting will ... on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: